Johnson MP, Krikke-Workel J, Patel CN, Morin SM, et al. Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine. Cephalalgia 2025;45:3331024251368757.
PMID: 40836866